A Phase III Randomized Double Blind Study of Letrozole Versus Placebo in Women With Primary Breast Cancer Completing Five or More Years of Adjuvant Tamoxifen
Latest Information Update: 19 Jun 2023
At a glance
- Drugs Letrozole (Primary)
- Indications Early breast cancer
- Focus Therapeutic Use
- 11 Apr 2021 Results of a secondary analysis of large adjuvant endocrine therapy trials (MA.17, MA.17R and MA.27) quantify the impact of competing risks on estimates of disease recurrence and benefit from therapypublished in the European Journal of Cancer
- 03 Aug 2011 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 03 Aug 2011 Planned end date (Dec 2010) added as reported by ClinicalTrials.gov (parent trial: NCT00003140).